ALFA Finder
19:34 IST
BSE
Management Change
Bacil Pharma Management Change
Mr. Dikshant Singh Panwar has resigned as Whole-Time Company Secretary and Compliance Officer of Bacil Pharma Limited, effective October 8, 2026.
Bacil Pharma Ltd
- Share price
- ₹16.95
- Market cap
- ₹24.33 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 38.5×Sector 43.8×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 6Board Meeting Date 6Financial Results 5Fund Raise 3Merger & Restructuring 2Management Change 2Board Meeting Outcome 2Partnership 1Capital Structure Change 1Annual Report 1Annual General Meeting 1
Time
2 announcements with these filters
18:22 IST
BSE
Management Change
Bacil Pharma Management Change
Bacil Pharma appointed Mr. Aayush Shah and Mr. Ankitkumar Surendrakumar Agrawal as Non-executive Independent Directors. The appointments are proposed for the upcoming Board Meeting.